Our clinical data demonstrated that NEK2 is overexpressed in cervical cancer and associated with the tumor stage and lymph node metastasis, indicating that NEK2 may act as an oncoprotein involved in cervical cancer tumorigenesis. This evidence concerns the gene NEK2 and neoplasm.